Sikora Karol
Imperial College , 79 Harley St , London , W1G 8PZ, UK E-mail:
Per Med. 2005 Mar;2(1):5-9. doi: 10.1517/17410541.2.1.5.
Karol Sikora is the Scientific Director of Medical Solutions Plc and Special Advisor to HCA International in the creation of the London Cancer Group - the largest UK cancer network outside the NHS in HCA's six major London private hospitals. This includes the construction of a major new international cancer center for care, teaching and research in London at the Harley St clinic. He is Professor of Cancer Medicine and honorary Consultant Oncologist at Imperial College School of Medicine, Hammersmith Hospital, London.
卡罗尔·西科拉是医疗解决方案有限公司的科学总监，也是HCA国际公司在创建伦敦癌症集团时的特别顾问，该集团是HCA在伦敦的六大私立医院中，位于英国国家医疗服务体系（NHS）之外的最大癌症网络。这包括在哈雷街诊所建设一座主要的新国际癌症中心，用于伦敦的护理、教学和研究。他是伦敦哈默史密斯医院帝国理工学院医学院的癌症医学教授和名誉肿瘤顾问。
